crazydoc
Well-known member
A little off topic:Script said:Yes, it requires less of the stuff and takes it directly to where it's needed, they say. Injection dosage 1 = inhalation dosage 3.
Equals patient treatable tripled. However, this med more effective in early stage of infection, it seems.
Other medication
Blood thinners against clotting
Gilead Sciences is making the injectable (estimated cost $4,460 per patient) and starting trials of the nebulized version. I doubt if the cost will be less even if the dose is cut. They will probably feel they can increase the price since it can save the cost of hospitalization for some patients (if it turns out it's useful for mild disease).
They also make Harvoni for hepatitis C, - the average wholesale USA cost for Harvoni was $1,125 per pill (one a day). An 8-week treatment course was $63,000 while a 12-week treatment course was $94,500 and a 24-week one $189,000. One reason given for the high price, besides the yada yada of development, was that it saved the patient (insurance) the cost of a liver transplant.
Hopefully the cost of remdesivir will come in at a reasonable level after taking development costs and a fair profit into consideration.
Here's another version:
Exactly how GILEAD arrived at the Harvoni price is clouded in secrecy however because of my contacts in the pharmaceutical industry I heard this story, which I believe is true.
When Gilead was certain that it had a cure for Hepatitis C it surveyed a number of USA based health insurance companies and asked how much it cost them if one of their customers caught Hepatitis C… from when they first contracted the disease until they died. It turned out that the cost was about US$200,000 per patient. So Gilead said something like ” so if we could cure 95% of your customers who have Hep C and charged about $80,000 per treatment that would be a price you would pay?”
So the story goes that Gilead worked out the cost of a person having Hep C to a health insurance company and then figured out what the maximum price they would be able to charge for Harvoni would be. The same logic applies to national health services in countries that offer health cover for their citizens.
So the price of Harvoni has nothing to do with research costs because Gilead purchased the technology for Harvoni. The price of Harvoni has nothing to do with manufacturing costs, because it actually costs very little indeed to manufacture a 12 week treatment of Harvoni. The Harvoni price has to do with greed… pure and simple corporate greed.
https://www.generichepatitiscdrugs.com/harvoni-price/